Paediatric Consumer Health in Slovakia

Paediatric Consumer Health in Slovakia

The paediatric consumer health market in Slovakia is expected to stabilise in 2024, following the rapid value growth seen in 2022 and 2023, driven mainly by supply issues in paediatric analgesics. A shortage of essential pain and fever medications like Panadol in 2023 led to a significant shift towards paediatric ibuprofen, resulting in stockpiling of Nurofen. However, with Panadol back in stock in 2024, demand for paediatric ibuprofen is expected to decline, while paediatric acetaminophen is se...

Euromonitor International's Paediatric Consumer Health in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.